Late chronic hemolysis after valve replacement for aortic stenosis. Relation to residual hypertrophy and impaired

O Lund1

  • 1Department of Thoracic and Cardiovascular Surgery, Skejby Sygehus, Aarhus University Hospital, Denmark.

Angiology
|October 1, 1990
PubMed

Insights

Intravascular hemolysis after aortic valve replacement is linked to left ventricular dysfunction and specific prosthesis types. Left ventricular hypertrophy and certain valve types correlate with elevated hemolysis markers, suggesting turbulent flow impacts red blood cells.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Hematology

Background:

  • Aortic valve replacement surgery can lead to intravascular hemolysis, a condition where red blood cells break down within blood vessels.
  • Long-term effects of prosthetic aortic valves on patient health, particularly left ventricular function, require further investigation.

Purpose of the Study:

  • To examine the relationship between intravascular hemolysis and patient status, including left ventricular (LV) function, in patients with aortic valve prostheses.
  • To identify factors contributing to hemolysis in patients with aortic stenosis treated with valve replacement.

Main Methods:

  • A cohort of 63 patients, 10-17 years post-aortic valve replacement for aortic stenosis, underwent assessment.
  • Radionuclide cardiography was used to evaluate left ventricular function.
  • Serum markers of hemolysis, including lactate dehydrogenase (LDH) and haptoglobin (HAPTO), were measured.

Main Results:

  • Elevated serum LDH and reduced haptoglobin were observed in most patients, indicating significant hemolysis.
  • Hemolysis markers (LDH) were higher in men, patients with ECG-defined left ventricular hypertrophy, advanced NYHA functional class, abnormal LV function, and those with Starr Edwards cloth-covered (SECC) prostheses.
  • ECG hypertrophy score correlated with LDH and inversely with LV ejection fraction and filling rates.

Conclusions:

  • Left ventricular hypertrophy and certain prosthetic valve types (SECC) are associated with increased intravascular hemolysis.
  • Malfunctioning left ventricles may contribute to turbulent blood flow around aortic prostheses, exacerbating hemolysis.
  • These findings highlight the interplay between cardiac structure, prosthesis type, and hemolysis in long-term aortic valve replacement outcomes.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...